How 2.4 Million is utilized (*Note: will is not an active verb):

1. Brenda Banwell, MD, at the Hospital for Sick Children, Toronto, Ontario, Canada, who is looking at the occurrence of CCSVI in children and teenagers with MS vs health controls.


2. Fiona Costello, MD, at the University of Calgary's Hotchkiss Brain Institute, Alberta, Canada, is using (OK – that’s active) ultrasonography and MRV to look at the prevalence of CCSVI in MS patients and controls.


3. Aaron Field, MD, at the University of Wisconsin School of Medicine and Public Health in Madisonwill use MRV in patients with early and advanced disease, as well as ultrasonography, to determine the prevalence of CCSVI.


4. Robert Fox, MD, from the Cleveland Clinic in Ohio, will also use MRV and ultrasonography, as well as MRI, to compare those with MS or CIS to
   healthy controls and patients with brain atrophy from Alzheimer's
   
   disease. They are also obtaining neck and brain tissue at autopsy to
   
   evaluate CCSVI.


5. Carlos Torres, MD, from Ottawa Hospital at the University of Ottawa, Ontario, Canada, is using (OK – that’s actively using the funds) 3-T MRI and Doppler ultrasonography to assess venous
   anatomy and iron deposits in 50 patients and 50 healthy controls.


6. Anthony Traboulsee MD from the University of British Columbia (UBC) Hospital MS
   Clinic, UBC Faculty of Medicine, and Katherine Knox, MD, from the
   
   Saskatoon MS Clinic at the University of Saskatchewan, Canada, are studying (yep – actively
   
   using) the prevalence of CCSVI in those with MS and controls, comparing
   
   results using catheter venography, ultrasonography, and MRV. Included
   
   in the control group will be family members, including identical
   
   unaffected twins of those with MS. And finally,


7. Jerry Wolinksy, MD, from the University of Texas Health Science Center in Houston, will also attempt to replicate Dr. Zamboni's ultrasonography methods, looking at the
   association of CCSVI in the major clinical types of MS as well as non-MS
   
   controls.

So we have three (3) wills (going to eventually use the funds?) and one who is looking (not sure if that is actively) out of seven (7) – that got a chunk of the 2.4 Million to A C T I V E L Y study CCSVI and MS. Only three (3) of the seven are studying or using their piece of the 2.4 Million.

AND, of the three, this is what Zamboni says of the research," One of these
diagnostic studies in Canada is led by Katherine Knox, director of the

MS Clinic of Saskatchewan, according to Zamboni, "not the slightest idea

of CCSVI." So 2.4 Million - went to what?

http://www.facebook.com/notes/rebecca-mccardle-lawrence/how-24-million-is-utilized-note-will-is-not-an-active-verb/453121317123